Glow Lifetech Corp. (GLOW.CN)
- Previous Close
0.0600 - Open
0.0600 - Bid --
- Ask --
- Day's Range
0.0600 - 0.0600 - 52 Week Range
0.0300 - 0.1400 - Volume
34,066 - Avg. Volume
251,241 - Market Cap (intraday)
9.08M - Beta (5Y Monthly) 1.92
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. It has exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron. The company engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. It provides its products under MOD and .decimal brands. Glow Lifetech Corp. was incorporated in 1988 and is headquartered in Etobicoke, Canada.
glowlifetech.comRecent News: GLOW.CN
View MorePerformance Overview: GLOW.CN
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLOW.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLOW.CN
View MoreValuation Measures
Market Cap
9.08M
Enterprise Value
8.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.36
Price/Book (mrq)
3.53
Enterprise Value/Revenue
9.80
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-37.78%
Return on Equity (ttm)
-345.27%
Revenue (ttm)
836.19k
Net Income Avi to Common (ttm)
-2.66M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.29M
Total Debt/Equity (mrq)
15.72%
Levered Free Cash Flow (ttm)
-1.67M